3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Breast Neoplasms
4
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
Endodermal Sinus Tumor
1
Central Nervous System Neoplasms
1
Castrate Resistant Prostate Cancer
1
Interventions
Ifosfamide
12
Filgrastim
12
Carboplatin
12
Peripheral Blood Stem Cell Transplantation
11
Etoposide
11
Paclitaxel
9
Cyclophosphamide
7
Cisplatin
6
Thiotepa
4
Flow Cytometry
4
Radiotherapy
3
Immunologic Techniques
3
pegfilgrastim
2
etoposide phosphate
2
Vinblastine
2
Temozolomide
2
Microarray Analysis
2
Methylprednisolone
2
Busulfan
2
Alemtuzumab
2
guadecitabine
1
fludarabine phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Topotecan
1
Tacrolimus
1
Sunitinib
1
Psychiatric Rehabilitation
1
Prednisone
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Testicular Germ Cell Tumor
×
Lenograstim
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled